| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.003 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | manumycin A | CTRPv2 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.11 | 0.004 |